To see this page, please, enable javaScript and styleSheets on your browser: Tools -> Internet Options ...
Reload !
Gene CMTM6TABLE OF CONTENTS / OPEN CLOSE ALL PARAGRAPHS
Summary back to top
Compact gene diagram back to top
247 supporting clones for gene CMTM6 back to top
cDNA accession
Links to the sequence
Tissue

most 5' clones
in red
Match
mRNA
From bp
to bp
in mRNA
From bp
to bp
in accs.
Clone encodes
complete protein
(with AA variation)
Features Anomalies
detected by
AceView
Accession
match over
(% length)
Base differences
relative to genome
(% identity)
AF479261 prostate adenocarcinoma .a 1 to 3865 1 to 3867 exact tiling clone, AAA Possibly primed on the genome, locally A rich (20/20 A in genome downstream of last aligned base) 3867/3867
(100 %)
44 diff
(98.9 %id)
AI568524 anaplastic oligodendroglioma, brain .a 199 to 621 423 to 1       423/423
(100 %)
0 diff
(100 %id)
AW006114 anaplastic oligodendroglioma, brain .a 199 to 644 446 to 1   tiling clone,   446/446
(100 %)
0 diff
(100 %id)
NM_017801.2   .a 500 to 3865 1 to 3366 exact RefSeq, AAA Possibly primed on the genome, locally A rich (20/20 A in genome downstream of last aligned base) 3366/3366
(100 %)
0 diff
(100 %id)
AL705312 human skeletal muscle .a 541 to 1083 1 to 543       543/543
(100 %)
0 diff
(100 %id)
BC002797 Ovary, adenocarcinoma .a 544 to 2440 1 to 1897 exact available from MGC, AAA Possibly primed on the genome, locally A rich (20/20 A in genome downstream of last aligned base) 1897/1897
(100 %)
0 diff
(100 %id)
BM193208 leukopheresis .a 550 to 1021 1 to 472       472/481
(98 %)
9 diff
(98.2 %id)
BP380167 uterus .a 550 to 1106 1 to 557       557/557
(100 %)
0 diff
(100 %id)
AK000403   .a 559 to 2440 1 to 1882 exact available from FLJ, AAA Possibly primed on the genome, locally A rich (20/20 A in genome downstream of last aligned base) 1882/1882
(100 %)
1 diff
(100.0 %id)
BE514833 adenocarcinoma cell line, ovary .a 563 to 965 1 to 403       403/403
(100 %)
0 diff
(100 %id)
CN427288 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .a 570 to 1307 1 to 738 exact     738/738
(100 %)
0 diff
(100 %id)
DB019496 esophageal, tumor tissue .a 570 to 1150 2 to 582   capped   581/581
(100 %)
0 diff
(100 %id)
DA838459 placenta .a 573 to 1144 2 to 573   capped   572/572
(100 %)
0 diff
(100 %id)
DA569669 whole embryo, mainly head .a 576 to 1364 31 to 827 exact capped   797/846
(94 %)
23 diff
(97.3 %id)
TI_44166997   .a 583 to 1196 93 to 704       612/704
(86 %)
10 diff
(98.6 %id)
BG719700 testis .a 585 to 1421 1 to 830 N3D     830/832
(99 %)
22 diff
(97.4 %id)
BI598747 brain, hypothalamus .a 585 to 1439 1 to 858 exact     858/859
(99 %)
14 diff
(98.4 %id)
DB213219 trachea .a 589 to 1130 2 to 543   capped   542/542
(100 %)
0 diff
(100 %id)
TI_45211064   .a 590 to 1439 92 to 944 exact     853/945
(90 %)
14 diff
(98.6 %id)
DB473781 hippocampus .a 593 to 1038 1 to 446       446/446
(100 %)
1 diff
(99.8 %id)
AA295541 Pancreas .a 594 to 814 1 to 221       221/221
(100 %)
0 diff
(100 %id)
DB451733 testis .a 597 to 1087 1 to 491       491/491
(100 %)
1 diff
(99.8 %id)
DB465219 hippocampus .a 597 to 1018 1 to 422       422/422
(100 %)
0 diff
(100 %id)
DB471415 hippocampus .a 597 to 1096 1 to 500       500/500
(100 %)
0 diff
(100 %id)
DB477731 hippocampus .a 597 to 1074 1 to 478       478/478
(100 %)
0 diff
(100 %id)
BM147709 leukopheresis .a 600 to 1121 1 to 522       522/523
(99 %)
7 diff
(98.7 %id)
BM150000 leukopheresis .a 600 to 949 1 to 350       350/350
(100 %)
11 diff
(96.9 %id)
BP374771 umbilical cord .a 600 to 1181 1 to 582       582/582
(100 %)
0 diff
(100 %id)
BJ995089 hepatoblastoma .a 601 to 1200 1 to 600       600/600
(100 %)
0 diff
(100 %id)
DA672384   .a 601 to 1170 2 to 571   capped   570/570
(100 %)
0 diff
(100 %id)
DA263776 caudate nucleus .a 602 to 1061 2 to 461   capped   460/460
(100 %)
0 diff
(100 %id)
DA378021 thalamus .a 602 to 1159 2 to 559   capped   558/558
(100 %)
0 diff
(100 %id)
DA426559 colon .a 602 to 895 2 to 295   capped   294/294
(100 %)
0 diff
(100 %id)
DA836942 placenta .a 602 to 1160 2 to 560   capped   559/559
(100 %)
0 diff
(100 %id)
DB193221 ovary, tumor tissue .a 602 to 1171 2 to 571   capped   570/570
(100 %)
0 diff
(100 %id)
BQ709106 Spleen .a 605 to 1478 20 to 898 exact     879/898
(97 %)
23 diff
(97.5 %id)
DA828904 placenta .a 605 to 1279 2 to 679 S163V Q164P L165A R166X P168T ... capped   678/679
(99 %)
11 diff
(98.4 %id)
DA656420   .a 606 to 1179 2 to 575   capped   574/574
(100 %)
0 diff
(100 %id)
DB009319 colon, tumor tissue .a 606 to 1170 2 to 566   capped   565/565
(100 %)
0 diff
(100 %id)
TI_44348150   .a 608 to 1369 83 to 843 L118M     761/844
(90 %)
13 diff
(98.5 %id)
AL710870 human skeletal muscle .a 609 to 1446 1 to 842 exact     842/850
(99 %)
9 diff
(99.0 %id)
AL710871 human skeletal muscle .a 609 to 1433 1 to 834 exact     834/836
(99 %)
14 diff
(98.4 %id)
BI559498 testis .a 609 to 1369 1 to 760 L118M     760/761
(99 %)
11 diff
(98.6 %id)
DB455370 testis .a 614 to 1086 1 to 473       473/473
(100 %)
1 diff
(99.8 %id)
DA729500   .a 615 to 1462 2 to 851 exact capped   850/850
(100 %)
13 diff
(98.5 %id)
DA729483   .a 617 to 1345 2 to 728 exact capped   727/731
(99 %)
4 diff
(99.5 %id)
BX486307   .a 618 to 1228 1 to 611 E2X R19X K101X K159X     611/611
(100 %)
0 diff
(100 %id)
BU787928 insulinoma, Pancreas .a 620 to 1215 1 to 596       596/596
(100 %)
4 diff
(99.4 %id)
DB095403 testis .a 623 to 1168 2 to 547   capped   546/546
(100 %)
0 diff
(100 %id)
BF171099 blood .a 632 to 759 1 to 127       127/150
(84 %)
12 diff
(92.0 %id)
TI_151761047   .a 636 to 1265 47 to 676 exact   Submitted on the opposite strand 630/1051
(59 %)
7 diff
(99.4 %id)
W94426 heart .a 637 to 1093 1 to 455     Submitted on the opposite strand 455/455
(100 %)
8 diff
(98.3 %id)
AW138094   .a 638 to 842 1 to 205     Submitted on the opposite strand 205/205
(100 %)
0 diff
(100 %id)
AW301108 colon, moderately differentiated adenocarcinoma .a 643 to 1117 1 to 475     Submitted on the opposite strand 475/475
(100 %)
0 diff
(100 %id)
BI819001 pooled brain, lung, testis .a 645 to 1471 1 to 832 exact     832/833
(99 %)
19 diff
(97.8 %id)
TI_57196474   .a 645 to 1471 34 to 865 exact     832/866
(96 %)
25 diff
(97.2 %id)
BM930386 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .a 645 to 1265 621 to 1 exact   Submitted on the opposite strand 621/621
(100 %)
0 diff
(100 %id)
AW080621 colon, moderately differentiated adenocarcinoma .a 659 to 1096 1 to 438     Submitted on the opposite strand 438/438
(100 %)
0 diff
(100 %id)
DB445227 testis .a 665 to 1081 1 to 417       417/427
(97 %)
1 diff
(99.8 %id)
CR457231   .a 666 to 1217 1 to 552 exact     552/552
(100 %)
1 diff
(99.9 %id)
AI972049 fibrotheoma, ovary .a 676 to 1231 1 to 556     Submitted on the opposite strand 556/556
(100 %)
0 diff
(100 %id)
AI951637 fibrotheoma, ovary .a 677 to 1162 1 to 486     Submitted on the opposite strand 486/486
(100 %)
0 diff
(100 %id)
BQ215404 melanotic melanoma, skin .a 677 to 1458 1 to 783       783/890
(87 %)
4 diff
(99.6 %id)
AI245855 Kidney .a 678 to 1162 1 to 485     Submitted on the opposite strand 485/485
(100 %)
0 diff
(100 %id)
AI860276 lung, squamous cell carcinoma, poorlydifferentiated (4 pooled tumors, including primary andmetastatic) .a 684 to 1161 1 to 478     Submitted on the opposite strand 478/478
(100 %)
0 diff
(100 %id)
BP269682 thyroid .a 803 to 1384 1 to 582       582/582
(100 %)
0 diff
(100 %id)
W92637 heart .a 858 to 1320 465 to 3     Submitted on the opposite strand 463/465
(99 %)
3 diff
(99.4 %id)
BQ776200 Bone, Human Chondrosarcoma Cell Line .a 885 to 1544 17 to 676     Submitted on the opposite strand 660/660
(100 %)
0 diff
(100 %id)
H81656 melanocyte .a 904 to 1353 1 to 451     Submitted on the opposite strand 451/451
(100 %)
17 diff
(96.3 %id)
AA773255 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .a 917 to 1320 406 to 3     Submitted on the opposite strand 404/406
(99 %)
0 diff
(100 %id)
BM788762 stomach .a 944 to 1604 1 to 661       661/661
(100 %)
0 diff
(100 %id)
BP300328   .a 974 to 1544 1 to 571       571/571
(100 %)
0 diff
(100 %id)
BG697031 skin .a 1003 to 1836 1 to 839       839/839
(100 %)
11 diff
(98.7 %id)
CA488654   .a 1013 to 1885 1 to 883       883/887
(99 %)
16 diff
(98.2 %id)
FN161667 breast carcinoma .a 1024 to 1120 98 to 1     Submitted on the opposite strand 98/98
(100 %)
1 diff
(99.0 %id)
AA227623 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .a 1062 to 1565 1 to 504       504/504
(100 %)
3 diff
(99.5 %id)
BU192458 large cell carcinoma, lung .a 1080 to 1956 10 to 893       884/893
(98 %)
6 diff
(99.4 %id)
TI_59392403   .a 1113 to 1749 88 to 724       637/637
(100 %)
14 diff
(97.9 %id)
BE866559 bladder, carcinoma, cell line .a 1136 to 1237 1 to 102       102/102
(100 %)
0 diff
(100 %id)
BG259873 bladder, transitional cell papilloma, cell line .a 1138 to 1781 1 to 645       645/1066
(60 %)
5 diff
(99.6 %id)
BE909900 epithelioid carcinoma, Pancreas .a 1157 to 1795 1 to 639       639/639
(100 %)
0 diff
(100 %id)
AA452507   .a 1188 to 1655 1 to 468       468/468
(100 %)
0 diff
(100 %id)
AA353492   .a 1196 to 1445 1 to 250       250/250
(100 %)
0 diff
(100 %id)
BM801316 duodenal adenocarcinoma, cell line, small intestine .a 1276 to 2075 1 to 808       808/913
(88 %)
13 diff
(98.6 %id)
BU506833 leiomyosarcoma, uterus .a 1293 to 2160 1 to 876       876/916
(95 %)
20 diff
(97.9 %id)
DB475304 hippocampus .a 1308 to 1782 1 to 475       475/475
(100 %)
2 diff
(99.6 %id)
DA717813   .a 1372 to 1948 2 to 578   capped   577/577
(100 %)
0 diff
(100 %id)
BM721042 eye, fetal eye .a 1397 to 2092 1 to 696       696/696
(100 %)
0 diff
(100 %id)
FN059633 breast carcinoma .a 1413 to 1503 1 to 91       91/91
(100 %)
3 diff
(96.8 %id)
EH353385   .a 1441 to 1511 1 to 73       73/74
(98 %)
3 diff
(96.0 %id)
CD743159 Alveolar Macrophage, lung .a 1459 to 2154 713 to 19   AAA Possibly primed on the genome, locally A rich (11/11 A in genome downstream of last aligned base) 695/695
(100 %)
1 diff
(99.9 %id)
BQ219936 epithelioid carcinoma, Pancreas .a 1465 to 2319 1 to 854       854/854
(100 %)
2 diff
(99.8 %id)
DA472325   .a 1555 to 2102 2 to 549   capped   548/548
(100 %)
0 diff
(100 %id)
CN427287 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .a 1560 to 2166 1 to 607       607/607
(100 %)
0 diff
(100 %id)
BG287941 bladder, transitional cell papilloma, cell line .a 1599 to 2361 1 to 764       764/898
(85 %)
10 diff
(98.9 %id)
AK172793   .a 1622 to 3865 1 to 2250   available from FLJ, AAA Possibly primed on the genome, locally A rich (20/20 A in genome downstream of last aligned base) 2250/2250
(100 %)
11 diff
(99.6 %id)
DA674169   .a 1622 to 2197 2 to 577   capped   576/576
(100 %)
0 diff
(100 %id)
BP292265 lung .a 1645 to 2230 1 to 586       586/586
(100 %)
0 diff
(100 %id)
CK903883 Islets of Langerhans, Pancreas .a 1657 to 2251 1 to 595       595/595
(100 %)
0 diff
(100 %id)
TI_151722105   .a 1658 to 2461 862 to 66       797/991
(80 %)
0 diff
(100 %id)
BM052901 Islets of Langerhans, Pancreas .a 1673 to 2200 1 to 528       528/528
(100 %)
0 diff
(100 %id)
CX758728 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass .a 1728 to 2460 732 to 1       732/732
(100 %)
4 diff
(99.5 %id)
AA877625 colon, colon tumor RER+ .a 1732 to 1989 1 to 258     Submitted on the opposite strand 258/258
(100 %)
0 diff
(100 %id)
AI376929   .a 1739 to 2185 1 to 447     Submitted on the opposite strand 447/447
(100 %)
0 diff
(100 %id)
FN084182 breast carcinoma .a 1757 to 1825 1 to 68       68/69
(98 %)
2 diff
(97.2 %id)
DA620831   .a 1786 to 2367 2 to 583   capped   582/582
(100 %)
0 diff
(100 %id)
CB216404 normal endometrium, mid-secretory phase,cycle day 23, uterus .a 1788 to 2391 1 to 604       604/604
(100 %)
0 diff
(100 %id)
BU194302 melanotic melanoma, skin .a 1789 to 2669 1 to 886       886/906
(97 %)
8 diff
(99.2 %id)
BU787652 insulinoma, Pancreas .a 1808 to 2457 650 to 1       650/650
(100 %)
0 diff
(100 %id)
TI_159723123   .a 1816 to 2470 686 to 32       655/1050
(62 %)
5 diff
(99.6 %id)
CA944908 Human Lung Epithelial cells, lung .a 1816 to 2458 643 to 1       643/668
(96 %)
0 diff
(100 %id)
AA054299 uterus .a 1852 to 2037 1 to 186       186/186
(100 %)
0 diff
(100 %id)
CK903882 Islets of Langerhans, Pancreas .a 1857 to 2447 591 to 1       591/591
(100 %)
0 diff
(100 %id)
BP223468 colon mucosa .a 1858 to 2460 1 to 603       603/616
(97 %)
0 diff
(100 %id)
AA935890 pooled .a 1877 to 2442 566 to 1       566/566
(100 %)
0 diff
(100 %id)
DB356355 whole embryo, mainly head .a 1888 to 2440 552 to 1       552/554
(99 %)
10 diff
(98.2 %id)
BG236004 blood, lymphocyte .a 1899 to 2449 551 to 1       551/551
(100 %)
0 diff
(100 %id)
TI_149307615   .a 1914 to 2440 620 to 94   AAA Possibly primed on the genome, locally A rich (20/20 A in genome downstream of last aligned base) 527/982
(53 %)
3 diff
(99.7 %id)
FN116023 breast carcinoma .a 1933 to 2009 1 to 77       77/78
(98 %)
3 diff
(96.2 %id)
DA672613   .a 1935 to 2538 2 to 605   capped   604/604
(100 %)
0 diff
(100 %id)
BF057174 pooled germ cell tumors .a 1936 to 2441 506 to 1       506/506
(100 %)
0 diff
(100 %id)
DB544127 hippocampus .a 1964 to 2440 1 to 477     Submitted on the opposite strand 477/477
(100 %)
0 diff
(100 %id)
BJ995090 hepatoblastoma .a 1965 to 2406 442 to 1       442/442
(100 %)
0 diff
(100 %id)
AA149186   .a 1969 to 2168 1 to 204   fully sequenced,   204/204
(100 %)
0 diff
(100 %id)
AI659203 Prostate .a 1971 to 2440 470 to 1       470/470
(100 %)
0 diff
(100 %id)
DB520778 testis .a 1972 to 2440 1 to 469     Submitted on the opposite strand 469/470
(99 %)
1 diff
(99.8 %id)
DB542551 hippocampus .a 1975 to 2440 1 to 467     Submitted on the opposite strand 467/467
(100 %)
1 diff
(99.8 %id)
BM052655 Islets of Langerhans, Pancreas .a 1985 to 2447 463 to 1       463/463
(100 %)
0 diff
(100 %id)
AW275899 lung, two pooled squamous cell carcinomas .a 1987 to 2442 456 to 1       456/456
(100 %)
0 diff
(100 %id)
AI147251 uterus .a 1988 to 2440 453 to 1       453/453
(100 %)
0 diff
(100 %id)
AW768585 lymph node, lymphoma, follicular mixed small and largecell .a 1988 to 2445 458 to 1       458/458
(100 %)
0 diff
(100 %id)
DB517224 testis .a 1989 to 2440 1 to 452     Submitted on the opposite strand 452/452
(100 %)
0 diff
(100 %id)
BF589522 Prostate .a 1990 to 2440 451 to 1       451/451
(100 %)
0 diff
(100 %id)
AI969247 lung, two pooled squamous cell carcinomas .a 1996 to 2444 449 to 1       449/449
(100 %)
0 diff
(100 %id)
DB510253 testis .a 2003 to 2438 1 to 436     Submitted on the opposite strand 436/438
(99 %)
3 diff
(99.4 %id)
AI701867 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors .a 2021 to 2447 427 to 1       427/427
(100 %)
0 diff
(100 %id)
AI950185 pooled germ cell tumors .a 2021 to 2442 422 to 1       422/422
(100 %)
0 diff
(100 %id)
BM459960 leiomyosarcoma, uterus .a 2024 to 2902 1 to 893       893/1099
(81 %)
33 diff
(97.0 %id)
AA811152 germinal center B cell .a 2029 to 2449 421 to 1       421/421
(100 %)
0 diff
(100 %id)
AA454092   .a 2033 to 2443 410 to 1       410/410
(100 %)
2 diff
(99.6 %id)
AW768610 lymph node, lymphoma, follicular mixed small and largecell .a 2040 to 2447 408 to 1       408/408
(100 %)
0 diff
(100 %id)
AI884604 serous papillary carcinoma, high grade, 2pooled tumors, uterus .a 2053 to 2445 393 to 1       393/393
(100 %)
0 diff
(100 %id)
AW875854 pnet .a 2054 to 2271 1 to 218       218/218
(100 %)
0 diff
(100 %id)
AI310825 2 pooled tumors (clear cell type), Kidney .a 2055 to 2143 89 to 1       89/89
(100 %)
0 diff
(100 %id)
AW613910 pooled germ cell tumors .a 2063 to 2441 379 to 1       379/379
(100 %)
0 diff
(100 %id)
AW272999 lung, two pooled squamous cell carcinomas .a 2066 to 2445 380 to 1       380/380
(100 %)
0 diff
(100 %id)
BM144893 leukopheresis .a 2086 to 2440 373 to 19   AAA Possibly primed on the genome, locally A rich (20/20 A in genome downstream of last aligned base) 355/355
(100 %)
7 diff
(98.1 %id)
AI635489 Kidney, renal cell tumor .a 2095 to 2445 351 to 1       351/351
(100 %)
0 diff
(100 %id)
AA227938 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .a 2107 to 2440 333 to 1       333/333
(100 %)
1 diff
(99.7 %id)
AA486154 lung .a 2116 to 2441 1 to 325   fully sequenced,   325/325
(100 %)
1 diff
(99.7 %id)
BM468152 melanotic melanoma, skin .a 2125 to 3011 1 to 894       894/1030
(86 %)
19 diff
(98.2 %id)
AI800671 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .a 2128 to 2450 323 to 1       323/323
(100 %)
0 diff
(100 %id)
AI375284 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .a 2135 to 2443 309 to 1       309/309
(100 %)
0 diff
(100 %id)
AA149187   .a 2138 to 2446 310 to 1   fully sequenced,   310/310
(100 %)
1 diff
(99.7 %id)
DB373526 placenta .a 2159 to 2440 282 to 1       282/282
(100 %)
2 diff
(99.3 %id)
AI446268 adenocarcinoma, Pancreas .a 2161 to 2450 290 to 1       290/290
(100 %)
0 diff
(100 %id)
BQ876728 sympathetic trunk .a 2163 to 2970 1 to 812   tiling clone,   812/926
(87 %)
15 diff
(98.4 %id)
BQ051117 leiomyosarcoma, uterus .a 2184 to 3004 1 to 816       816/1075
(75 %)
29 diff
(97.4 %id)
FN156463 breast carcinoma .a 2217 to 2305 1 to 89       89/89
(100 %)
0 diff
(100 %id)
FN159314 breast carcinoma .a 2230 to 2309 1 to 81       81/86
(94 %)
2 diff
(97.7 %id)
AA486092 lung .a 2347 to 2444 97 to 1   fully sequenced,   97/97
(100 %)
0 diff
(100 %id)
GD144242   .a 2361 to 2440 1 to 80   AAA Possibly primed on the genome, locally A rich (20/20 A in genome downstream of last aligned base) 80/80
(100 %)
2 diff
(97.5 %id)
ES310715 scalp interfollicular dermis, skin .a 2384 to 2858 19 to 501       483/501
(96 %)
6 diff
(98.9 %id)
BM716075 eye, Retina Foveal and Macular .a 2395 to 3012 1 to 617       617/617
(100 %)
2 diff
(99.7 %id)
TI_151764740   .a 2395 to 3017 105 to 732       628/1131
(55 %)
65 diff
(94.3 %id)
BY995230   .a 2402 to 3040 10 to 650       641/650
(98 %)
6 diff
(99.1 %id)
BQ221096 melanotic melanoma, skin .a 2454 to 3315 1 to 864       864/867
(99 %)
5 diff
(99.5 %id)
CN359370 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .a 2461 to 3013 1 to 553       553/553
(100 %)
0 diff
(100 %id)
BC009187 Ovary, adenocarcinoma .a 2467 to 3857 1 to 1392   available from MGC, AAA Possibly primed on the genome, locally A rich (20/20 A in genome downstream of last aligned base) 1392/1392
(100 %)
4 diff
(99.8 %id)
BU161742 melanotic melanoma, skin .a 2468 to 3264 1 to 806       806/872
(92 %)
22 diff
(97.5 %id)
CN359373 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .a 2477 to 2749 1 to 273       273/273
(100 %)
0 diff
(100 %id)
BU178844 eye, retinoblastoma .a 2479 to 3350 1 to 875       875/889
(98 %)
21 diff
(97.7 %id)
CX166759 human embryonic stem cells differentiated toan early endodermal cell type .a 2482 to 3277 1 to 797       797/797
(100 %)
1 diff
(99.9 %id)
BE741349 adenocarcinoma cell line, ovary .a 2484 to 3228 1 to 744   available from MGC,   744/974
(76 %)
42 diff
(95.7 %id)
BI061620 uterus_tumor .a 2489 to 3109 1 to 621       621/621
(100 %)
0 diff
(100 %id)
BQ435115 melanotic melanoma, skin .a 2494 to 3343 12 to 867       856/888
(96 %)
16 diff
(98.2 %id)
FN052383 breast carcinoma .a 2501 to 2589 1 to 89       89/89
(100 %)
0 diff
(100 %id)
CB146300 Liver .a 2509 to 3040 1 to 532       532/532
(100 %)
0 diff
(100 %id)
CN359369 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .a 2519 to 2854 1 to 336       336/336
(100 %)
0 diff
(100 %id)
AA102271   .a 2526 to 2897 1 to 372       372/372
(100 %)
1 diff
(99.8 %id)
BF879776 lung_tumor .a 2559 to 2927 86 to 459       374/459
(81 %)
6 diff
(98.7 %id)
BM023586 Islets of Langerhans, Pancreas .a 2593 to 3092 1 to 499       499/499
(100 %)
4 diff
(99.2 %id)
FN100717 breast carcinoma .a 2603 to 2703 1 to 100       100/100
(100 %)
2 diff
(98.0 %id)
FN095871 breast carcinoma .a 2669 to 2769 1 to 99       99/99
(100 %)
2 diff
(98.0 %id)
BU929936 placenta .a 2731 to 3506 1 to 780       780/781
(99 %)
14 diff
(98.3 %id)
AF116694 Liver .a 2790 to 3865 1 to 1077       1077/1083
(99 %)
8 diff
(99.3 %id)
R64155 placenta .a 2806 to 3178 1 to 392     Submitted on the opposite strand 392/392
(100 %)
21 diff
(94.7 %id)
BM767327 Ascites, stomach .a 2846 to 3467 1 to 622       622/622
(100 %)
0 diff
(100 %id)
EL955619 eyeball .a 2847 to 3253 46 to 448       403/448
(89 %)
6 diff
(98.7 %id)
EL954996 eyeball .a 2848 to 3354 1 to 506       506/506
(100 %)
4 diff
(99.3 %id)
AA429329 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .a 2857 to 3250 1 to 394     Possibly primed on the genome, locally A rich (20/20 A in genome downstream of last aligned base) 394/394
(100 %)
1 diff
(99.8 %id)
TI_149302717   .a 2863 to 3865 1049 to 57   tiling clone, AAA Possibly primed on the genome, locally A rich (20/20 A in genome downstream of last aligned base) 993/1004
(98 %)
62 diff
(93.9 %id)
FN108468 breast carcinoma .a 2901 to 3006 1 to 110       110/110
(100 %)
5 diff
(95.5 %id)
BG285643 bladder, transitional cell papilloma, cell line .a 2931 to 3724 1 to 786       786/786
(100 %)
21 diff
(97.4 %id)
CB046295 2 pooled tumors (clear cell type), Kidney .a 2983 to 3376 2 to 395   fully sequenced, Possibly primed on the genome, locally A rich (20/20 A in genome downstream of last aligned base) 394/395
(99 %)
5 diff
(98.8 %id)
BU860130 adenocarcinoma, cell line, breast .a 3000 to 3556 1 to 557   AAA Possibly primed on the genome, locally A rich (20/20 A in genome downstream of last aligned base) 557/557
(100 %)
0 diff
(100 %id)
AW612804 carcinoid, lung .a 3034 to 3386 1 to 353     Submitted on the opposite strand 353/353
(100 %)
0 diff
(100 %id)
TI_149312660   .a 3039 to 3865 914 to 95   AAA Possibly primed on the genome, locally A rich (20/20 A in genome downstream of last aligned base) 820/963
(85 %)
31 diff
(96.8 %id)
BC027472 Ovary, adenocarcinoma .a 3048 to 3865 1 to 820   available from MGC, AAA Possibly primed on the genome, locally A rich (20/20 A in genome downstream of last aligned base) 820/820
(100 %)
2 diff
(99.8 %id)
FN052647 breast carcinoma .a 3049 to 3161 1 to 113       113/113
(100 %)
0 diff
(100 %id)
BF033115 adenocarcinoma, ovary .a 3069 to 3817 1 to 760   available from MGC,   760/835
(91 %)
28 diff
(96.7 %id)
FN052558 breast carcinoma .a 3082 to 3182 1 to 101       101/101
(100 %)
0 diff
(100 %id)
BQ006773 Chondrosarcoma, Left Pelvis .a 3086 to 3857 788 to 19   AAA Possibly primed on the genome, locally A rich (20/20 A in genome downstream of last aligned base) 770/770
(100 %)
3 diff
(99.7 %id)
BU621280 cell lines, Chondrosarcoma .a 3088 to 3865 794 to 19   AAA Possibly primed on the genome, locally A rich (20/20 A in genome downstream of last aligned base) 776/776
(100 %)
4 diff
(99.5 %id)
BM980865 lung, Primary Lung Cystic Fibrosis EpithelialCells .a 3090 to 3865 794 to 19   AAA Possibly primed on the genome, locally A rich (20/20 A in genome downstream of last aligned base) 776/776
(100 %)
0 diff
(100 %id)
BU608730 Human Lung Epithelial cells, lung .a 3090 to 3857 783 to 19   AAA Possibly primed on the genome, locally A rich (20/20 A in genome downstream of last aligned base) 765/765
(100 %)
3 diff
(99.7 %id)
AW105138 pooled .a 3096 to 3555 460 to 1       460/460
(100 %)
0 diff
(100 %id)
BQ000642 Fibrosarcoma .a 3110 to 3857 764 to 19   AAA Possibly primed on the genome, locally A rich (20/20 A in genome downstream of last aligned base) 746/746
(100 %)
2 diff
(99.8 %id)
TI_149305980   .a 3113 to 3865 863 to 122   AAA Possibly primed on the genome, locally A rich (20/20 A in genome downstream of last aligned base) 742/857
(86 %)
28 diff
(96.8 %id)
BQ008107 Chondrosarcoma, Left Pelvis .a 3196 to 3865 687 to 19   AAA Possibly primed on the genome, locally A rich (20/20 A in genome downstream of last aligned base) 669/671
(99 %)
1 diff
(99.9 %id)
BM998446 lung, Metastatic Chondrosarcoma .a 3217 to 3865 667 to 19   AAA Possibly primed on the genome, locally A rich (20/20 A in genome downstream of last aligned base) 649/649
(100 %)
0 diff
(100 %id)
BM927081 brain .a 3239 to 3865 1 to 627       627/627
(100 %)
0 diff
(100 %id)
FN076153 breast carcinoma .a 3261 to 3364 1 to 107       107/109
(98 %)
4 diff
(96.4 %id)
BM150653 leukopheresis .a 3308 to 3863 574 to 18   AAA Possibly primed on the genome, locally A rich (20/20 A in genome downstream of last aligned base) 557/568
(98 %)
0 diff
(100 %id)
BM023287 Islets of Langerhans, Pancreas .a 3309 to 3863 566 to 11       556/566
(98 %)
0 diff
(100 %id)
FN173296 breast carcinoma .a 3315 to 3395 1 to 81       81/81
(100 %)
1 diff
(98.8 %id)
FN089659 breast carcinoma .a 3316 to 3383 1 to 68       68/69
(98 %)
1 diff
(98.6 %id)
AA934030 pooled germ cell tumors .a 3326 to 3858 533 to 1       533/533
(100 %)
0 diff
(100 %id)
BE710706 head_neck .a 3328 to 3676 5 to 358       354/358
(98 %)
6 diff
(98.4 %id)
CB046294 2 pooled tumors (clear cell type), Kidney .a 3346 to 3865 546 to 27   fully sequenced, AAA Possibly primed on the genome, locally A rich (20/20 A in genome downstream of last aligned base) 520/520
(100 %)
0 diff
(100 %id)
AI697418 poorly-differentiated endometrialadenocarcinoma, 2 pooled tumors, uterus .a 3350 to 3857 508 to 1       508/508
(100 %)
0 diff
(100 %id)
AI953353 Kidney .a 3359 to 3865 507 to 1       507/507
(100 %)
0 diff
(100 %id)
BP397496 pancreatic islet .a 3366 to 3865 1 to 500     Submitted on the opposite strand 500/500
(100 %)
0 diff
(100 %id)
AW613158 colon, moderately-differentiated adenocarcinoma .a 3370 to 3858 489 to 1       489/489
(100 %)
0 diff
(100 %id)
TI_57187936   .a 3373 to 3865 53 to 540   AAA Possibly primed on the genome, locally A rich (20/20 A in genome downstream of last aligned base) 488/488
(100 %)
7 diff
(98.6 %id)
AI379173 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .a 3380 to 3865 486 to 1       486/486
(100 %)
0 diff
(100 %id)
AA977188 pooled germ cell tumors .a 3388 to 3865 478 to 1       478/478
(100 %)
0 diff
(100 %id)
FN124612 breast carcinoma .a 3398 to 3529 1 to 126       126/126
(100 %)
6 diff
(95.3 %id)
DB546334 hippocampus .a 3413 to 3865 1 to 454     Submitted on the opposite strand 454/454
(100 %)
1 diff
(99.8 %id)
AW614171 Kidney .a 3413 to 3857 445 to 1       445/445
(100 %)
0 diff
(100 %id)
AI014520 pooled .a 3423 to 3860 438 to 1       438/438
(100 %)
0 diff
(100 %id)
AW473967 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors .a 3423 to 3858 436 to 1       436/436
(100 %)
0 diff
(100 %id)
AW513525 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors .a 3434 to 3858 425 to 1       425/425
(100 %)
0 diff
(100 %id)
DB531760 hippocampus .a 3439 to 3865 1 to 428     Submitted on the opposite strand 428/428
(100 %)
3 diff
(99.3 %id)
AA425108 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .a 3440 to 3857 434 to 15   AAA Possibly primed on the genome, locally A rich (20/20 A in genome downstream of last aligned base) 420/420
(100 %)
2 diff
(99.6 %id)
AA086215   .a 3451 to 3865 418 to 2       417/418
(99 %)
0 diff
(100 %id)
AA366069 Pancreas .a 3465 to 3621 1 to 157       157/157
(100 %)
0 diff
(100 %id)
AA748810 germinal center B cell .a 3467 to 3865 411 to 13   AAA Possibly primed on the genome, locally A rich (20/20 A in genome downstream of last aligned base) 399/399
(100 %)
0 diff
(100 %id)
BU733770 eye, Retina Foveal and Macular .a 3472 to 3865 413 to 19   AAA Possibly primed on the genome, locally A rich (20/20 A in genome downstream of last aligned base) 395/395
(100 %)
5 diff
(98.8 %id)
AA235840 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .a 3479 to 3865 387 to 1       387/387
(100 %)
0 diff
(100 %id)
AI800521 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .a 3482 to 3865 384 to 1       384/384
(100 %)
0 diff
(100 %id)
AI739209 colon, colon tumor, RER+ .a 3486 to 3865 395 to 16   AAA Possibly primed on the genome, locally A rich (20/20 A in genome downstream of last aligned base) 380/380
(100 %)
0 diff
(100 %id)
AA921742 pooled .a 3491 to 3860 370 to 1       370/370
(100 %)
0 diff
(100 %id)
AA788827 parathyroid gland, parathyroid tumor .a 3492 to 3690 199 to 1       199/199
(100 %)
0 diff
(100 %id)
AW013882   .a 3501 to 3865 382 to 18   AAA Possibly primed on the genome, locally A rich (20/20 A in genome downstream of last aligned base) 365/365
(100 %)
0 diff
(100 %id)
BQ005360 Chondrosarcoma, Left Pelvis .a 3556 to 3865 328 to 19   AAA Possibly primed on the genome, locally A rich (20/20 A in genome downstream of last aligned base) 310/310
(100 %)
0 diff
(100 %id)
N47216 multiple sclerosis lesions .a 3562 to 3865 304 to 1       304/304
(100 %)
0 diff
(100 %id)
AI275932 poorly-differentiated endometrialadenocarcinoma, 2 pooled tumors, uterus .a 3572 to 3865 294 to 1       294/294
(100 %)
0 diff
(100 %id)
AI611155 pooled germ cell tumors .a 3587 to 3865 279 to 1       279/279
(100 %)
0 diff
(100 %id)
BU730052 eye, Retina Foveal and Macular .a 3595 to 3865 289 to 19   AAA Possibly primed on the genome, locally A rich (20/20 A in genome downstream of last aligned base) 271/271
(100 %)
1 diff
(99.7 %id)
AW193753 serous papillary carcinoma, high grade, 2pooled tumors, uterus .a 3608 to 3865 258 to 1       258/258
(100 %)
0 diff
(100 %id)
FN172179 breast carcinoma .a 3630 to 3747 1 to 112       112/115
(97 %)
7 diff
(94.0 %id)
FN056665 breast carcinoma .a 3664 to 3785 1 to 123       123/123
(100 %)
1 diff
(99.2 %id)
AA360287 lymph node .a 3689 to 3863 1 to 175       175/175
(100 %)
0 diff
(100 %id)
AV684992 hepatocellular carcinoma .b 1 to 613 1 to 610 K103H S104R S105I D106F F107I ... tiling clone,   614/625
(98 %)
13 diff
(98.0 %id)
AV687232 hepatocellular carcinoma .b 1 to 633 1 to 628 exact tiling clone,   628/660
(95 %)
14 diff
(97.9 %id)
BC042995 testis .c-u 1 to 2038 997 to 3040 exact tiling clone, available from MGC, AAA Possibly primed on the genome, locally A rich (11/11 A in genome downstream of last aligned base) 2044/3040
(67 %)
6 diff
(99.9 %id)
CD674671 eye, lens .c-u 283 to 947 665 to 1 exact   Submitted on the opposite strand 665/665
(100 %)
3 diff
(99.6 %id)
TI_154101044   Gene CMTM6, variant not shown       AAA Suspected internal deletion, this clone was ignored    
? Gene Summary Gene on genome mRNA:.a, .b, .c-u Alternative mRNAs features, proteins, introns, exons, sequences Expression Tissue Function, regulation, related genes C